Multiple Sclerosis Biomarkers: The Future of Disease Detection and Management
…a multiple sclerosis biomarker from research into clinical practice requires comprehensive characterization and testing. Ultrasensitive, large-scale biomarker detection methods could significantly accelerate GFAP’s validation and further implementation in clinical settings….
read more